COVID-19 scenario and recommendations on the continuity of immunobiological therapy in patients with atopic asthma in Brazil and Latin America.
Rafael de Oliveira ResendeVinícius José de OliveiraAlessandro Sousa CorreaPedro Trica de AraújoErnesto Akio TaketomiPublished in: Expert review of respiratory medicine (2022)
Although the association between asthma and COVID-19 has been under investigation, immunobiological treatment should follow the consensus-based statements recommending the maintenance of the therapy unless the patient is infected by the SARS-CoV-2. However, it must be closely followed by the medical assistant.